LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

Search

Twist Bioscience Corp

Closed

SectorHealthcare

31.9 -0.56

Overview

Share price change

24h

Current

Min

31.51

Max

33.44

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

3.2M

-21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+19.83% upside

Market Stats

By TradingEconomics

Market Cap

31M

1.9B

Previous open

32.46

Previous close

31.9

News Sentiment

By Acuity

50%

50%

159 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

17 Dec 2025, 23:50 UTC

Hot Stocks

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 Dec 2025, 23:20 UTC

Earnings

Correction to Micron Logs Sales Jump Article

17 Dec 2025, 23:07 UTC

Earnings

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 Dec 2025, 21:37 UTC

Earnings

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 Dec 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 Dec 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 Dec 2025, 23:06 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 Dec 2025, 23:05 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 Dec 2025, 23:04 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 Dec 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 Dec 2025, 23:02 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 Dec 2025, 22:59 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 Dec 2025, 22:57 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 Dec 2025, 22:56 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 Dec 2025, 22:55 UTC

Acquisitions, Mergers, Takeovers

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 Dec 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 Dec 2025, 21:58 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 Dec 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

17 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 Dec 2025, 21:46 UTC

Earnings

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 Dec 2025, 21:20 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 Dec 2025, 21:10 UTC

Earnings

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 Dec 2025, 21:05 UTC

Earnings

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 Dec 2025, 21:04 UTC

Earnings

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 Dec 2025, 21:04 UTC

Earnings

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 Dec 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 Dec 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 Dec 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 Dec 2025, 21:02 UTC

Earnings

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 Dec 2025, 21:01 UTC

Earnings

Micron Technology 1Q Rev $13.64B >MU

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

19.83% upside

12 Months Forecast

Average 38.5 USD  19.83%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

159 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat